Since its discovery at the end of the nineteenth century, Moraxella (Branhamella) catarrhalis has undergone several changes of nomenclature and periodic changes in its perceived status as either a commensal or a pathogen. Molecular analysis based on DNA hybridisation or 16s rDNA sequence comparisons has established its phylogenetic position as a member of the Moraxellaceae and shown that it is related more closely to Acinetobacter spp. than to the genus Neisseria in which it was placed formerly. However, confusion with phenotypically similar Neisseria spp. can occur in the routine diagnostic laboratory if appropriate identification tests are not performed. M. catarrhalis is now accepted as the third commonest pathogen of the respiratory tract after Streptococcus pneumoniae and Haemophilus injluenzae. It is a significant cause of otitis media and sinusitis in children and of lower respiratory tract infections in adults, especially those with underlying chest disease. Nosocomial spread of infection, especially within respiratory wards, has been reported. Invasive infection is uncommon, but analysis of reports for England and Wales between 1992 and 1995 revealed 89 cases of M. catarrhalis bacteraemia, with the peak incidence in children aged 1-2 years. Carriage rates of M. catarrhalis are high in children and in the elderly, but its role as a commensal organism has probably been overstated in the past. Approximately 90% of strains are now plactamase positive and, given that the first such strain was reported in 1976, this represents a dramatic increase in frequency over the last 20 years which has not been paralleled in any other species. The BRO-1 and BRO-2 P-lactamase enzymes of M. catarrhalis are found in other Moraxellaceae, but are not related to P-lactamases of any other species and their origin is therefore unknown. Molecular and typing studies have shown that the M. catarrhalis species is genetically heterogeneous and these methods have aided epidemiological investigation. Studies of factors that may be related to pathogenicity have shown the existence of three serotypes of lipooligosaccharide and the presence of fimbriae and a possible capsule. Some strains are serum-resistant, probably by virtue of interference with complement action, whilst transferrin-and lactoferrinbinding proteins enable the organism to obtain iron from its environment. An antibody response in humans to various M. catarrhalis antigens, including highly conserved outermembrane proteins, has been demonstrated. Increased understanding of the organism's pathogenic properties and the host response to it may help to identify suitable vaccine targets or lead to other strategies to prevent infection. Whilst it remains, at present, the third most important respiratory pathogen, the impact of immunisation strategies for other organisms may change this position. The speed with which M. catarrhalis acquired p-lactamase demonstrates the capacity of this organism to surprise us.
Introduction
accepted as a pathogen, although until relatively recently it was considered to be a harmless commensal Moraxella catarrhalis is an aerobic, oxidase-positive, of the upper respiratory tract. It is morphologically and gram-negative diplococcus which is now generally phenotypically similar to Neisseria spp. and, in the past, this has resulted in the misidentification of M.
-

Moraxella lacunataT
Moraxella ca ta rrhalis adult pharynx. M. catarrhalis is now recognised as an important cause of respiratory tract infections in the elderly and in those with pre-existing respiratory disease, as a common cause of otitis media in children, and as an occasional cause of invasive disease. [26] .
The most common cause of morbidity due to M. catarrhalis in adults is exacerbation of chronic bronchitis in patients with pre-existing pulmonary disease [27] . M. catarrhalis is also the third most commonly isolated pathogen from the lower respiratory tract after S. pneumoniae and H. influenzae, and is often isolated in conjunction with one of these two pathogens. Slevin et al. [27] catarrhalis in their sputum and confirmed the presence of the organism in the lower respiratory tract in 10 patients, of whom four yielded pure cultures of M. catarrhalis [29] . Lastly, a case control study that compared patients with M. catarrhalis isolated from expectorated sputum against controls with commensal Neisseria isolates confirmed an association between M. catarrhalis and the clinical features of bronchopulmonary infection [30] . Thus, there is good evidence to support the view that M. catarrhalis is a respiratory pathogen. Lower respiratory tract infection with M. catarrhalis is more likely to affect elderly patients and is more common in winter [31] . There is some evidence that, even in the absence of changes in laboratory technical or interpretive practices, the incidence of M. catarrhalis respiratory infection is increasing [32, 331. Although exacerbation of chronic bronchitis is the commonest manifestation of M. catarrhalis infection, pneumonia may also occur. Wright et al. [34] described 42 cases of pneumonia diagnosed on the basis of a pure culture of M. catarrhalis from sputum together with the presence of a new infiltrate on chest X-ray or autopsy evidence of pneumonia. These patients were predominantly elderly with a serious underlying disease and, although the pneumonia itself was described as a mild illness, 45% of the patients died of their underlying disease within 3 months. M. catarrhalis pneumonia is therefore associated with a poor prognosis. Bacterial tracheitis is a further rare manifestation of M. catarrhalis infection which has been reported several times in children, sometimes in association with respiratory syncytial virus infection [ 3 5 -3 71.
Invasive disease caused by M. catarrhalis is relatively uncommon, but is well-documented in the literature. Catlin [I] extensively reviewed the evidence that M. catarrhalis has caused meningitis, bacteraemia and endocarditis. It is difficult to assess the accuracy of strain identification in many older reports, but it seems likely that M. catarrhalis has been responsible for all of the above conditions at some time. In particular, there is good evidence that M. catarrhalis is an occasional cause of bacteraemia [38] , with episodes reported in association with pneumonia [39] , otitis media [40] and AIDS [41] . [42] . The age distribution for 87 of these patients (Fig. 2a) shows that infection was commonest in children aged < 10 years, with 46% of cases in this age range. Further analysis of the latter group (Fig. 2b) shows that cases peak at the age of 1 year and tail off by the age of 5 years, although there were four cases in babies aged 6 10 days. Over the entire age range, there were similar numbers of cases in 
Nosocom ial infection
There is now convincing evidence that the spread of M. catarrhalis within hospital wards can lead to significant outbreaks of nosocomial infection, Epidemiological evidence for this was presented by Ahmad et al. [44] , but these authors were unable to confirm their suspicions because of the absence at that time of a suitable typing system. Patterson et al. [45] applied REA to isolates from an apparent outbreak in an intensive care setting and confirmed isolation of the same strain from five patients and two staff members, all of whom were symptomatic. 
Antibiotic susceptibility
Resistance to p-lactam antibiotics
A retrospective study in the USA of 18 M. catarrhalis isolates dating from 1952 to 1975 found no plactamase-producing strains before the first p-lactamase-positive isolates in 1976 [50] . Similarly, 46 French isolates dating from 1970 to 1976 were found to be P-lactamase-negative [51] , with the first plactamase-positive French isolate reported in 1977 [52] .
The subsequent increase in incidence of P-lactamasepositive M. catarrhalis isolates has been described as the fastest increase in prevalence of any known plactamase within a bacterial species [53] . Surveys of resistance in the UK in 1991, and in Denmark in 1994, showed that 91% and 84% of M. catarrhalis strains, respectively, were P-lactamase-positive [ 19, 541. The reason for the dramatic emergence of P-lactamaseproducing strains is not clear, and although it has been attributed to increased prescribing of p-lactam antibiotics, increases in the prevalence of p-lactamasepositive strains of other comparable species such as N gonorrhoeae or H. injuenzae have not been nearly so spectacular.
M. catarrhalis P-lactamases are of two types which can be distinguished by isoelectric focusing [52, 551 and, as they are quite different from P-lactamase enzymes in any other genus, their original source is unknown [53] . The two enzymes are phenotypically similar and have been designated BRO-1 (previously called Ravasio type) and BRO-2 (previously called 1908-type), the name deriving from Banhamella and Mg-axella [SO] . BRO-1 is the most common and is present in c. 90% of p-lactamase-positive strains [5l, 56, 571. Strains with the BRO-1 P-lactamase have 25-fold higher ampicillin MICs than p-lactamase-negative strains, while in those strains with the BRO-2 enzyme, ampicillin MICs are only four-fold higher than in plactamase negative strains [57] . It is thought that this difference is caused by higher levels of production of the BRO-1 enzyme (2-3-fold more than BRO-2) rather than any intrinsic difference in enzyme activity WI.
BRO P-lactamases are found only in M. catarrhalis and in two closely related species, M. lacunata [50] and M. nonliquefaciens [50, 581 . Conjugal transfer of BRO P-lactamase from one M. catarrhalis strain to another was demonstrated by Kamme et al. [59] . Transfer from M. nonliquefaciens to M. catarrhalis has also been demonstrated [59, 601 . The genetics of P-lactamase production in M. catarrhalis are poorly understood. Both BRO-1 and BRO-2 genes are thought to be chromosomal, although it has been proposed that both enzymes are the product of one gene and derive from a membrane-bound precursor enzyme [61] . Claims that the genes are plasmid-borne [62] have not been supported by other investigators, but there is no doubting the efficiency with which the enzyme has spread throughout the species population, leading to the suggestion that the genes are on a conjugal transposon [ 531. The involvement of nonpathogenic Moraxella spp. in the gene pool may be significant in promoting spread, as widespread carriage of such organisms increases the opportunity for genetic exchange [63] . Other than the enzymes discussed above, there have been single reports of a further P-lactamase, designated BRO-3 [64] , and of a strain with a plasmid-mediated TEM-1 p-lactamase ~5 1 .
Antimicrobial susceptibility testing of M. catarrhalis reveals a bimodal distribution of MIC values of ampicillin among p-lactamase-positive strains, probably reflecting the presence of two populations with different P-lactamase enzymes [54] . However, disk testing for sensitivity to ampicillin is problematic, as many P-lactamase-positive strains show large zones of inhibition and would be classed as sensitive according to normal test procedures [53, 541 . The clinical significance of this is uncertain, but in the absence of extensive trials, it is probably better to err on the side of caution in routine practice and to test isolates that are apparently sensitive by standard disk sensitivity tests for the presence of p-lactamase by a chromogenic method. Both research groups that highlighted this problem have recommended that, whatever the results of disk sensitivity tests, all P-lactamasepositive isolates should be reported as ampicillin-or amoxycillin-resistant [ 53, 541. There is evidence that M. catarrhalis /3-lactamases can protect other respiratory pathogens from /I-lactam antibiotics when present in mixed infections. Hol et al. [66] 
Resistance to non-P-lactam antibiotics
Other than P-lactamase-mediated resistance to penicillins and inherent resistance to trimethoprim, M. catarrhalis remains generally sensitive to macrolide, cephalosporin and tetracycline antibiotics [54, 681 . It is also normally sensitive to co-amoxyclav. Erythromycinresistant strains have been reported occasionally [27, 691 and co-trimoxazole is reported to be effective despite resistance to its trimethoprim component [69] . Fung et al. [54] reported that 6.5% of their strains were resistant to sulphamethoxazole. M. catarrhalis strains are almost universally susceptible to tetracycline, although two pairs of strains isolated from Texas and England [ 701 were tetracycline-resistant because of the presence of a non-transferable TetB determinant. Resistant strains have also been isolated in Spain [65] and China [71] . Roberts et al. [70] suggested that the TetB determinant may have transferred from Haemophilus spp. by conjugation or transformation. Aminoglycoside resistance has been observed, with one study reporting 17% streptomycin resistance in Spanish isolates and smaller numbers of kanamycin-and neomycin-resistant isolates [ 551.
Typing methods
Until relatively recently there was no established, discriminatory typing system for M. catarrhalis strain differentiation. Phenotypic methods such as serotyping [ 721, isoelectric focusing of P-lactamase enzymes [ 561, bacteriocin typing 11731, SDS-PAGE of outer-membrane proteins (OMPs) [74] , esterase electrophoresis [75] and gel electrophoresis of soluble proteins [76] have all been used with varying degrees of success. A range of phenotypic characteristics, including serum resistance, haemagglutination, P-lactamase production and antimicrobial susceptibility pattern, was used by Soto-Hernandez et al. [77] to discriminate between M. catarrhah strains. However, none of these phenotypic methods has provided a high level of discrimination between closely related strains.
The first genotypic method relied on analysis of plasmid DNA [78] , but proved unsuccessful because of the small number of plasmids found. A chromosomal DNA-based typing method (REA) was used by Patterson et al. [45] to confirm a suspected outbreak of nosocomial infection. In this method, chromosomal DNA is purified and cleaved with restriction endonucleases to provide strain-specific fingerprints which are resolved on agarose gels. REA proved highly discriminatory for isolates of M. catarrhalis in this study although the method was not compared to other typing schemes. We have successfully used three methods for the investigation of suspected nosocomial infection: SDS-PAGE of whole cell polypeptides; immunoblots of these gels with normal human serum; and REA with the frequently cutting enzyme TaqI [46-481. In subsequent studies (personal unpublished results), we have used pulsed-field gel electrophoresis (PFGE) with the rare-cutting enzymes NotI and SmaI. PFGE is similar to REA, except that fewer DNA fragments are obtained because of the use of restriction endonucleases that cut less frequently. The large fragments of DNA produced cannot be resolved by conventional gel electrophoresis, but separation can be achieved by switching the direction of the electric current continuously to allow the resolution of DNA fragments from c. 50 kb to several megabases in length. PFGE with NotI and SmaI has also been used by a Japanese group to type 38 hospital isolates of M. catarrhalis [79] . Their results suggest that this method is highly suitable for use in typing studies and the publication of recommended criteria for the more general application of PFGE to bacterial typing may lead to this becoming the molecular method of choice [W.
Population genetics
To date there have been no published studies on the population genetics of M. catarrhalis. Studies on other organisms, such as Escherichia coli [81] , have attempted to assess whether an organism has a clonal population structure. In a clonal population, genetic recombination between strains or other species is undetectable and changes to the bacterial genome are thought to occur by mutation and localised DNA rearrangement [ 821. Clonal populations are characterised by the existence of similar strains separated in time and space, e.g., strains isolated years apart from different countries. Non-clonal populations arise when recombination between strains or other species occurs frequently. This type of population is genetically heterogeneous with little identity between strains, even those from similar sources. The method chosen to examine the genetics of a population is very important, as the greater the discriminatory power of the technique used, the more accurate will be the results obtained. We have performed a limited study of M. catarrhalis population genetics with REA, PGFE and multi-locus enzyme electrophoresis (MLEE). MLEE, which is the most commonly used method in the study of bacterial population genetics, relies on comparisons of the electrophoretic mobility of known proteins, giving information (indirectly) about the strain at the genetic level. Preliminary results (personal unpublished results) suggest that most M. catarrhalis isolates are different from each other, but we have found occasional isolates obtained from different countries several years apart which are indistinguishable by all methods used. This leads us to believe that M. catarrhalis may have a similar population structure to that found in N. meningitidis, i.e., one with a non-clonal structure, but with the occasional emergence of a successful 'epidemic ' clone.
Pathogenicity and virulence
As M. catarrhah has become accepted more widely as a pathogen, interest in potential virulence factors has increased. Endotoxin or lipopolysaccharide (LPS) plays a major role i n , the pathogenesis of gramnegative infection and therefore presents an obvious area for study. In A? gonorrhoeae, LPS is associated with membrane vesicles or blebs. Similar vesicles are found in M. catarrhalis broth culture supernates [83] and three major serotypes of M. catarrhalis LPS have been described by Vanechoutte et al. [72] , accounting for 95% of all strains. The LPS of M. catarrhalis, [86] , and P-D-Gal-(1-4)-a-~-GlcNAc for serotype C [87] . There is some cross-reaction between serotypes, particularly between serotypes A and C [72, 861 . In a study with an animal model, formalin-killed isolates of M. catarrhalis were shown to produce effusions in the middle ear of chinchilla, indicating a possible role for endotoxin in the disease process [88] . Storm Fomsgaard et al. [89] also found that M. catarrhalis LPS had a similar effect to enterobacterial LPS in mice and in the Limulus amoebocyte lysate assay.
Pili or fimbriae are protein filaments that extend from the surface of bacteria and have a role in adherence to host mucosal epithelial cells [90] . Fimbriae have been found in some, but not all, strains of M. catarrhalis [Sl] . Adherence of the bacterium to respiratory mucosal cells is a primary step in the pathogenesis of infection and prevents the organism from being washed away by the mucociliary escalator. Hybridisation with a pilus gene from M. bovis showed the existence of class 4 pilus genes in four M. catarrhalis strains [91] . This class of pilus is present in other pathogenic bacteria, such as N. gonorrhoeae [92, 931 , N meningitidis [94] , Pseudomonas aeruginosa [95] and Vihrio cholerae [96] , as well as other pathogenic Moraxella spp. [94, 97, 981 . Electron microscopy by Marrs and Weir [91] indicated the presence of at least one other pilus class in M. catarrhalis, as is common in other bacterial species [99] . Other investigators have demonstrated the presence of non-type 4 fimbriae both in vitro [loo, 1011 and in vivo [102] . Recent studies of the nature of the receptor that mediates adherence of M. catarrhalis to the respiratory epithelium suggest that fimbrial adherence involves interaction with a specific glycosphingolipid receptor [103] . Identification of a specific receptor that mediates adherence opens up the possibility of inhibiting the binding of M. catarrhalis to the mucosal surface and thus preventing colonisation and subsequent infection.
Complement plays an important role in host defences against N meningitidis and N. gonorrhoeae, as illustrated by two studies which showed that patients deficient with respect to complement were about 8000-fold more likely to acquire an infection by these organisms [104, 1051. Resistance to the action of complement is therefore an important virulence factor, especially in gram-negative pathogens [ 1061. There is good evidence that some M. catarrhalis strains produce a protein that interferes with the formation of the membrane attack complex of complement and thus renders the organism 'serum resistant' [ 1071. Helminen et al. [lo81 showed that a genetically manipulated M. catarrhalis strain which does not express the CopB OMP lacks the serum resistance of the parent strain, but that this property returns with restoration of gene expression. A survey of strains carried by healthy schoolchildren and isolated from adults with lower respiratory tract infections showed differences in the prevalence of serum resistance in these different groups [ 1091. Serum-resistant strains were more likely to be found in younger children and in symptomatic adults than in older children. Hol et al. [lo91 did not study carriage in children aged < 4 years, but it is interesting to speculate that the peak incidence of M. catarrhalis bacteraemia in younger children discussed earlier may be associated with an increased incidence in the carriage of serum-resistant strains.
Human pathogens require iron to grow and differentiate, yet the blood and mucosae of man are ironlimited environments because of the binding of iron by human transferrin in serum and lactoferrin in mucus. Pathogenic bacteria have therefore evolved several mechanisms for iron-uptake, commonly involving the production of siderophores. These are secreted compounds that chelate iron in the environment and are then taken up by specific OMP receptor proteins [ Possession of a capsule is an important virulence mechanism for many organisms, usually preventing phagocytosis. There have been reports of a polysaccharide capsule in M. catarrhalis similar to that of N gonorrhoeae , but this has not been welldefined. One further possible virulence mechanism is suggested by a study of five bacterial species, including M. catarrhalis, in infection of the lower respiratory tract. This showed that M. catarrhalis synthesises clinically significant amounts of histamine, as do I? aeruginosa and H. influenzae [ 11 91. Histamine is involved in restriction of the airways resulting from smooth muscle contraction and slowing of ciliary beat in vitro [120] , leading to a depressed rate of mucus clearance and increased colonisation of the respiratory tract.
Host responses
Serological evidence for infection by M. catarrhalis was presented by Eliasson [121] , who found antibodies to P antigen in most healthy adult sera. Goldblatt et al. [122] demonstrated that the IgG response to M. catarrhalis in children increases after the age of I year, but the predominant response to OMPs is in the IgG3 subclass and does not appear until after the age of 4 years. The delayed appearance of antibody to The conserved nature of these proteins has raised interest in the possibility that one or more might form the basis of a protective vaccine. Helminen et al. [125] reported a monoclonal antibody (MAb) specific for a 300-400-kDa surface antigen (UspAP) that enhanced pulmonary clearance of the organism in passively immunised mice. Recombinant antigen was recognised in immunoblots by convalescent serum, but not acute phase serum, from patients with M. catarrhalis pneumonia. Antibody responses to the CopB antigen [126] and to the 84-kDa antigen OMP B1 have also been demonstrated in patients with M. catarrhalis infections [ 1271. A further possible vaccine candidate is the heat-modifiable OMP C/D, which is also expressed on the surface of the intact bacterium [128] . Antibodies to LPS have been measured in patients with M. catarrhalis lower respiratory infections, but do not appear to show a serotype-specific response [ 1291.
Conclusions
Since its initial recognition at the start of the century, and following a long intervening period of neglect, M. catarrhalis has now been rediscovered as a pathogen. In terms of clinical significance, it clearly comes third in the respiratory tract after S. pneurnoniae and H. inpuenzae, but the impact of immunisation for both these species may disturb this balance in years to come. Lower respiratory tract infection in patients with underlying chest disease is the best known example of its clinical impact, but the potential of the organism to cause nosocomial infection is less well recognised. Otitis media in children caused by M. catarrhalis represents significant morbidity in simple numerical terms and may contribute to hearing problems in later life. The epidemiology of M. catarrhalis bacteraemia deserves further study in order to confirm the findings presented here of a peak in children aged between 1 and 2 years. Current work is now focusing on molecular aspects of the organism's epidemiology and pathogenicity. As it becomes more fully understood, the prevention of infection by M. catarrhalis may become possible. Vaccine targets include the highly conserved major OMPs, while interference with fimbrial adherence may also provide options for therapy or prevention. The speed with which this organism acquired the ability to produce plactamase warns us that this is a pathogen which should not be under-rated.
